IL110302A - Esters of carbamic acids and pharmaceutical preparations containing them - Google Patents
Esters of carbamic acids and pharmaceutical preparations containing themInfo
- Publication number
- IL110302A IL110302A IL110302A IL11030294A IL110302A IL 110302 A IL110302 A IL 110302A IL 110302 A IL110302 A IL 110302A IL 11030294 A IL11030294 A IL 11030294A IL 110302 A IL110302 A IL 110302A
- Authority
- IL
- Israel
- Prior art keywords
- alkyl
- piperidine
- hydrogen
- alkylcarbonyl
- ester
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/095,140 US5952354A (en) | 1993-07-21 | 1993-07-21 | Tris carbamic acid esters: inhibitors of cholesterol absorption |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL110302A0 IL110302A0 (en) | 1994-10-21 |
| IL110302A true IL110302A (en) | 1998-06-15 |
Family
ID=22250071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL110302A IL110302A (en) | 1993-07-21 | 1994-07-13 | Esters of carbamic acids and pharmaceutical preparations containing them |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5952354A (fi) |
| EP (1) | EP0635501A1 (fi) |
| JP (1) | JPH0789934A (fi) |
| KR (1) | KR950003269A (fi) |
| AU (1) | AU692157B2 (fi) |
| BR (1) | BR9402852A (fi) |
| CA (1) | CA2128116A1 (fi) |
| FI (1) | FI943441A (fi) |
| HU (1) | HU216790B (fi) |
| IL (1) | IL110302A (fi) |
| MX (1) | MX9405430A (fi) |
| NZ (1) | NZ264032A (fi) |
| RU (1) | RU2130928C1 (fi) |
| SG (1) | SG47596A1 (fi) |
| TW (1) | TW369527B (fi) |
| ZA (1) | ZA945214B (fi) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5527804A (en) * | 1994-06-13 | 1996-06-18 | American Home Products Corporation | 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors or cholesterol absorption |
| PL190034B1 (pl) | 1995-10-05 | 2005-10-31 | Kyoto Pharmaceutical Ind | Nowe pochodne heterocykliczne i kompozycje farmaceutyczne zawierające nowe pochodne heterocykliczne |
| US5952506A (en) * | 1997-04-24 | 1999-09-14 | American Home Products Corporation | Process for the synthesis of 4- 6- (hexylcarbamoyloxy) hexylcarbamoyloxy!-piperidine-1-carboxylic acid 4-phenoxyphenyl ester |
| AU6946998A (en) * | 1997-04-24 | 1998-11-13 | American Home Products Corporation | Process for the synthesis of 4-{6-(hexylcarbamoyloxy) hexylcarbamoyloxy}-piperidine-1- carboxylic acid 4-phenoxyphenyl ester |
| EP2234493A4 (en) * | 2007-12-21 | 2011-05-25 | Univ Cincinnati | THERAPEUTIC USE OF CARBOXYLESTERLIPASE INHIBITORS |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2800105A1 (de) * | 1977-01-11 | 1978-07-13 | Ciba Geigy Ag | Verwendung von diphenylaethern als algizide |
| JPS5671058A (en) * | 1979-11-12 | 1981-06-13 | Mitsui Toatsu Chem Inc | Phenoxyphenylcarbamic ester derivative |
| DE3702876A1 (de) * | 1987-01-31 | 1988-08-11 | Merck Patent Gmbh | Optisch aktive verbindungen |
| FR2612186B1 (fr) * | 1987-03-09 | 1989-07-21 | Poudres & Explosifs Ste Nale | Carbonyl 2,2' bis (alkyl-4 oxadiazolidines-1,2,4-diones-3,5), leur procede de preparation et leur utilisation comme intermediaires de synthese dans la preparation de carbamates |
| US5142094A (en) * | 1989-11-06 | 1992-08-25 | Warner-Lambert Company | Aryl substituted carbamate derivatives which are acat inhibitors |
| IL95994A0 (en) * | 1989-11-15 | 1991-07-18 | American Home Prod | Carbamate esters and pharmaceutical compositions containing them |
| US5112859A (en) * | 1990-09-14 | 1992-05-12 | American Home Products Corporation | Biphenyl amide cholesterol ester hydrolase inhibitors |
| US5169844A (en) * | 1991-12-20 | 1992-12-08 | American Home Products Corporation | 4-substituted piperidinecarboxylic acid esters: inhibition of cholesterol absorption |
-
1993
- 1993-07-21 US US08/095,140 patent/US5952354A/en not_active Expired - Fee Related
-
1994
- 1994-01-10 TW TW083100154A patent/TW369527B/zh active
- 1994-07-13 IL IL110302A patent/IL110302A/en not_active IP Right Cessation
- 1994-07-15 RU RU94026296A patent/RU2130928C1/ru active
- 1994-07-15 MX MX9405430A patent/MX9405430A/es unknown
- 1994-07-15 CA CA002128116A patent/CA2128116A1/en not_active Abandoned
- 1994-07-15 ZA ZA945214A patent/ZA945214B/xx unknown
- 1994-07-15 HU HU9402108A patent/HU216790B/hu not_active IP Right Cessation
- 1994-07-18 AU AU67520/94A patent/AU692157B2/en not_active Ceased
- 1994-07-18 BR BR9402852A patent/BR9402852A/pt not_active Application Discontinuation
- 1994-07-18 KR KR1019940017234A patent/KR950003269A/ko not_active Application Discontinuation
- 1994-07-18 JP JP6165075A patent/JPH0789934A/ja active Pending
- 1994-07-18 NZ NZ264032A patent/NZ264032A/en unknown
- 1994-07-19 SG SG1996003025A patent/SG47596A1/en unknown
- 1994-07-19 EP EP94305305A patent/EP0635501A1/en not_active Ceased
- 1994-07-20 FI FI943441A patent/FI943441A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2130928C1 (ru) | 1999-05-27 |
| AU6752094A (en) | 1995-02-02 |
| NZ264032A (en) | 1995-12-21 |
| AU692157B2 (en) | 1998-06-04 |
| US5952354A (en) | 1999-09-14 |
| MX9405430A (es) | 1995-01-31 |
| RU94026296A (ru) | 1997-05-27 |
| FI943441A (fi) | 1995-01-22 |
| BR9402852A (pt) | 1995-04-04 |
| CA2128116A1 (en) | 1995-01-22 |
| HU216790B (hu) | 1999-08-30 |
| EP0635501A1 (en) | 1995-01-25 |
| KR950003269A (ko) | 1995-02-16 |
| SG47596A1 (en) | 1998-04-17 |
| HUT70942A (en) | 1995-11-28 |
| ZA945214B (en) | 1996-01-15 |
| TW369527B (en) | 1999-09-11 |
| IL110302A0 (en) | 1994-10-21 |
| JPH0789934A (ja) | 1995-04-04 |
| FI943441A0 (fi) | 1994-07-20 |
| HU9402108D0 (en) | 1994-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11214578B2 (en) | Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof | |
| EP1536797B1 (en) | 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough | |
| EP0383579B1 (en) | N-Phenyl-N-(4-piperidinyl)amides useful as analgesics | |
| US5935951A (en) | 1-acyl-4-aliphatylaminopiperidine compounds | |
| EP0815080B1 (en) | Di-substituted 1,4-piperidine esters and amides having 5-ht4 antagonistic activity | |
| FR2676053A1 (fr) | Nouveaux composes dialkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| KR20070050076A (ko) | 아미도 화합물 및 약제로서의 이의 용도 | |
| CA2596444A1 (en) | 1-acylamino-2-hydroxy-3-amino-w-arylalkanes as renin inhibitors | |
| WO2011059048A1 (ja) | 新規アミド誘導体 | |
| EP1043310B1 (en) | Biphenylamidine derivatives | |
| EP0742208A1 (en) | 2-Ureido-benzamide derivatives | |
| JPWO2020138398A1 (ja) | リジン特異的脱メチル化酵素１を阻害する新規化合物、その製造方法及びその用途 | |
| IL110302A (en) | Esters of carbamic acids and pharmaceutical preparations containing them | |
| JPH06247850A (ja) | １２−リポキシゲナーゼ阻害剤 | |
| US6964974B2 (en) | 2,3-oxidosqualene-lanosterol cyclase inhibitors | |
| JP2004509106A (ja) | ニコチン性アセチルコリン受容体アゴニストとしての（２−アザ−ビシクロ［２．２．１］ヘプト−７−イル）メタノール誘導体 | |
| EP0913393B1 (en) | Arylacetic amide derivative or salt thereof, and pharmaceutical comprising it | |
| AU701447B2 (en) | 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors of cholesterol absorption | |
| JP3054742B2 (ja) | アミノナフタレン化合物 | |
| WO2022120048A1 (en) | Hdac inhibitors | |
| MXPA96006135A (en) | Steres of 4-carbamoiloxi-piperidin-1-carboxilico acid: inhibitors of the absolute of solids | |
| JP2005535685A (ja) | トリプターゼ阻害剤としてのピロリジン誘導体 | |
| JP2012107006A (ja) | Ｎ−置換−環状アミノ誘導体の製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| RH | Patent void |